Med LifeBSE:M -2.42%91 PEG Ratio is 85.77 as of Jul. 04, 2026, which is 1236% above its 10-year median of 6.42. GuruFocus rates BSE:M with a GF Score™ of 91/100 and a GF Value™ of lei7.84 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 225 Healthcare Providers & Services companies, Med Life ranks worse than 98.22% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Med Life's PE Ratio without NRI is 1,612.50. Med Life's 5-Year EBITDA growth rate is 18.80%. Therefore, Med Life's PEG Ratio for today is 85.77.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Med Life's PEG Ratio or its related term are showing as below:
BSE:M'
s PEG Ratio Range Over the Past 10 Years
Min: 0.27 Med: 6.42 Max: 169.61
Current: 87.9
During the past 11 years, Med Life's highest PEG Ratio was 169.61. The lowest was 0.27. And the median was 6.42.
BSE:M's PEG Ratio is ranked worse than 98.22% of 225
companies
in the Healthcare Providers & Services industry
Industry Median: 1.41
vs BSE:M: 87.90
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Med Life (BSE:M) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Med Life PEG Ratio Related Terms
Med Life PEG Ratio Historical Data
* Premium members only.
The historical data trend for Med Life's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Med Life's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Med Life's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Med Life (BSE:M) has a PEG Ratio of 85.77 as of Jul. 04, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Med Life and its competitors. This is 1236% above median its historical median of 6.42. Over the past decade, Med Life's PEG Ratio has ranged from 0.27 to 169.61. According to the industry distribution chart, Med Life ranks #221 out of 225 companies in the Healthcare Providers & Services industry, placing it in the top 98.2%.
Is Med Life's PEG Ratio too high?
Med Life's current PEG Ratio of 85.77 is 1236% above median its 10-year median of 6.42. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 169.61. The Healthcare Providers & Services industry median PEG Ratio is 1.41. Med Life's value of 85.77 is 5983% above this industry median. Based on the distribution chart, Med Life ranks #221 out of 225 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Med Life has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #221 out of 225 companies for PEG Ratio. This places Med Life in the lower half of its industry. The industry median PEG Ratio is 1.41. Med Life's value of 85.77 is 5983% above this benchmark. Historically, Med Life's own PEG Ratio has ranged from 0.27 to 169.61 over the past decade. While the company's 10-year median is 6.42 vs. the industry median of 1.41, Med Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.41, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current PEG Ratio of 85.77 is 5983% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current PEG Ratio is 85.77, which is 1236% above median its own 10-year median of 6.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Significantly Overvalued. The stock's GF Value™ is lei7.84, compared to a current price of lei12.90 — trading 64.5% above its estimated fair value. The current PEG Ratio is 85.77, which is 1236% above median its 10-year median of 6.42 and 5983% above the Healthcare Providers & Services industry median of 1.41. Med Life's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Med Life (BSE:M), the current PEG Ratio is 85.77 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (BSE:M) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei12.90 is trading 64.5% above its estimated GF Value™ of lei7.84.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for BSE:M:
PEG Ratio: 85.77 (1236% above median its 10-year median of 6.42)
GF Value™: lei7.84 vs. price of lei12.90 (64.5% above fair value)
Industry Position: 5983% above the Healthcare Providers & Services median (#221 of 225)
No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
91GF Score
Get the complete analysis for BSE:M
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:M has been successfully added to your 
